Skip to content

IV Administration SetRecalls & reported problems across all models

B. Braun Medical Inc. · 153 models in the FDA device registry

Data updated Oct 16, 2026 from official FDA records · Editorial policy

67 open recalls name at least one IV Administration Set model. Check whether yours is affected in the recall details, and contact the manufacturer or your healthcare provider.

Adverse event reports
281
Deaths reported
0
Injuries reported
0
Recalls
68

We found 153 models of IV Administration Set by B. Braun Medical Inc. in the FDA's device registry (GUDID). Together they are named in 281 adverse event reports in the FDA's MAUDE database, received between Nov 17, 2016 and Sep 25, 2026 — classified as 281 malfunctions.

The most frequently reported specific device problem is “Leak/Splash” (111 reports).

68 FDA recall records name at least one of these models by its device identifier, 67 still open.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event. Widely used products collect more reports, so totals can't be used to compare products or estimate failure rates. Only reports that name a model's exact device identifier are counted. What reports can and can't tell you · How this data works

Reports received per month, all models

Nov 2023: 0 reportsDec 2023: 2 reportsJan 2024: 4 reportsFeb 2024: 1 reportsMar 2024: 2 reportsApr 2024: 3 reportsMay 2024: 2 reportsJun 2024: 1 reportsJul 2024: 2 reportsAug 2024: 1 reportsSep 2024: 0 reportsOct 2024: 6 reportsNov 2024: 1 reportsDec 2024: 0 reportsJan 2025: 2 reportsFeb 2025: 1 reportsMar 2025: 0 reportsApr 2025: 1 reportsMay 2025: 2 reportsJun 2025: 2 reportsJul 2025: 0 reportsAug 2025: 2 reportsSep 2025: 1 reportsOct 2025: 1 reportsNov 2025: 4 reportsDec 2025: 3 reportsJan 2026: 0 reportsFeb 2026: 3 reportsMar 2026: 14 reportsApr 2026: 2 reportsMay 2026: 8 reportsJun 2026: 3 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 2 reportsOct 2026: 0 reports20242025202614
Last 36 months. The most recent month may be incomplete.

IV Administration Set recalls

FDA recall records that name at least one of these models by its device identifier, newest first. Each recall usually covers specific models or lots, so check the details.

  1. Oct 29, 2025Open, Classified

    Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).

    Z-0718-2026 · Root cause: Process control · Recall details · FDA record ↗

  2. Oct 29, 2025Open, Classified

    Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).

    Z-0717-2026 · Root cause: Process control · Recall details · FDA record ↗

  3. Oct 29, 2025Open, Classified

    Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).

    Z-0705-2026 · Root cause: Process control · Recall details · FDA record ↗

  4. Oct 29, 2025Open, Classified

    Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).

    Z-0704-2026 · Root cause: Process control · Recall details · FDA record ↗

  5. Oct 29, 2025Open, Classified

    Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).

    Z-0703-2026 · Root cause: Process control · Recall details · FDA record ↗

  6. Oct 29, 2025Open, Classified

    Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).

    Z-0702-2026 · Root cause: Process control · names 2 of these models · Recall details · FDA record ↗

  7. Oct 29, 2025Open, Classified

    Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).

    Z-0701-2026 · Root cause: Process control · Recall details · FDA record ↗

  8. Oct 29, 2025Open, Classified

    Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).

    Z-0700-2026 · Root cause: Process control · names 2 of these models · Recall details · FDA record ↗

  9. Oct 29, 2025Open, Classified

    Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).

    Z-0699-2026 · Root cause: Process control · Recall details · FDA record ↗

  10. Oct 29, 2025Open, Classified

    Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).

    Z-0698-2026 · Root cause: Process control · Recall details · FDA record ↗

  11. Oct 29, 2025Open, Classified

    Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).

    Z-0697-2026 · Root cause: Process control · Recall details · FDA record ↗

  12. Oct 29, 2025Open, Classified

    Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).

    Z-0696-2026 · Root cause: Process control · Recall details · FDA record ↗

  13. Oct 29, 2025Open, Classified

    Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).

    Z-0695-2026 · Root cause: Process control · names 2 of these models · Recall details · FDA record ↗

  14. Oct 29, 2025Open, Classified

    Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).

    Z-0694-2026 · Root cause: Process control · Recall details · FDA record ↗

  15. Oct 29, 2025Open, Classified

    Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).

    Z-0693-2026 · Root cause: Process control · Recall details · FDA record ↗

  16. Oct 29, 2025Open, Classified

    Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).

    Z-0692-2026 · Root cause: Process control · Recall details · FDA record ↗

  17. Oct 29, 2025Open, Classified

    Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).

    Z-0691-2026 · Root cause: Process control · Recall details · FDA record ↗

  18. Oct 29, 2025Open, Classified

    Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).

    Z-0690-2026 · Root cause: Process control · Recall details · FDA record ↗

  19. Oct 29, 2025Open, Classified

    Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).

    Z-0689-2026 · Root cause: Process control · Recall details · FDA record ↗

  20. Oct 29, 2025Open, Classified

    Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).

    Z-0688-2026 · Root cause: Process control · Recall details · FDA record ↗

  21. Oct 29, 2025Open, Classified

    Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).

    Z-0687-2026 · Root cause: Process control · Recall details · FDA record ↗

  22. Oct 29, 2025Open, Classified

    Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).

    Z-0686-2026 · Root cause: Process control · Recall details · FDA record ↗

  23. Oct 29, 2025Open, Classified

    Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).

    Z-0685-2026 · Root cause: Process control · names 2 of these models · Recall details · FDA record ↗

  24. Oct 29, 2025Open, Classified

    Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).

    Z-0684-2026 · Root cause: Process control · Recall details · FDA record ↗

  25. Oct 29, 2025Open, Classified

    Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).

    Z-0683-2026 · Root cause: Process control · Recall details · FDA record ↗

  26. Oct 29, 2025Open, Classified

    Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).

    Z-0682-2026 · Root cause: Process control · names 3 of these models · Recall details · FDA record ↗

  27. Oct 29, 2025Open, Classified

    Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).

    Z-0681-2026 · Root cause: Process control · Recall details · FDA record ↗

  28. Oct 29, 2025Open, Classified

    Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).

    Z-0680-2026 · Root cause: Process control · Recall details · FDA record ↗

  29. Oct 29, 2025Open, Classified

    Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).

    Z-0679-2026 · Root cause: Process control · Recall details · FDA record ↗

  30. Oct 29, 2025Open, Classified

    Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).

    Z-0678-2026 · Root cause: Process control · Recall details · FDA record ↗

…and 38 older recalls, listed on each model's page.

Most reported IV Administration Set problems

Device problems

  • Leak/Splash111
  • Fluid/Blood Leak68
  • Contamination /Decontamination Problem28
  • Air/Gas in Device17
  • Free or Unrestricted Flow13
  • Labelling, Instructions for Use or Training Problem13
  • Device Operates Differently Than Expected9
  • Inaccurate Flow Rate8

Patient problems

  • No Clinical Signs, Symptoms or Conditions170
  • No Known Impact Or Consequence To Patient53
  • No Consequences Or Impact To Patient35
  • Hemorrhage/Blood Loss/Bleeding7
  • Blood Loss6
  • Chemical Exposure4
  • Dyspnea3
  • Fall2

IV Administration Set models

153 models, 100 per page, most reported first. Each model has its own page with its reports, recalls and device details.

Recent IV Administration Set adverse event reports

The 15 most recent reports across all models, in the reporter's own words as published by the FDA.

Other B. Braun Medical Inc. products

All B. Braun Medical Inc. devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page